Cardiac amyloidosis: the heart of the matter

Area of Science:

• Cardiology
• Pathology
• Genetics

Background:

• Amyloidosis involves extracellular deposition of fibrillar proteins in organs, notably the heart.
• Cardiac amyloidosis can be primary or secondary to systemic or heredofamilial forms.
• Heart infiltration leads to restrictive cardiomyopathy, congestive heart failure, and conduction abnormalities.

Purpose of the Study:

• To review current diagnostic approaches for cardiac amyloidosis.
• To outline methods for assessing disease severity.
• To discuss contemporary treatment strategies.

Main Methods:

• Review of recent advancements in imaging techniques.
• Evaluation of extracardiac tissue biopsy utility.
• Analysis of diagnostic criteria for amyloidogenic protein identification.

Main Results:

• Non-invasive methods like advanced imaging and extracardiac biopsies reduce reliance on endomyocardial biopsy.
• Accurate identification of the amyloidogenic protein is essential for appropriate management.
• Prognosis remains poor, dependent on disease type and organ dysfunction.

Conclusions:

• Early diagnosis is critical for initiating timely therapy, as advanced disease limits treatment options.
• Current approaches aim to improve diagnostic accuracy and patient outcomes.
• Despite treatment advances, patient prognosis necessitates prompt intervention.